This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (57)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Topic Collections  • Statistics and Research Methods  • Gastroenterology  • Gastrointestinal Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Richard S. Blumberg, MD; Warren Strober, MD

JAMA. 2001;285:643-647.

Inflammatory bowel disease is a chronic inflammatory condition of the gastrointestinal tract that manifests as ulcerative colitis and Crohn disease. Both these clinical entities result from interrelated genetic and environmental factors that may be channeled through an abnormality in mucosal immune function, possibly due to dysregulated or excessive T helper cell (T_H)1 (Crohn disease) or T_H2 (ulcerative colitis) responses. This article reviews current knowledge of the role of immune factors in inflammatory bowel disease and the potential therapeutic strategies that target the pathways of T_H1- or T_H2-induced inflammation.

Author Affiliations: Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass (Dr Blumberg); Mucosal Immunity Section, National Institutes of Health, Bethesda, Md (Dr Strober).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTER

Antisperm Antibodies in Inflammatory Bowel Disease
Marco Rossato and Carlo Foresta
Arch Intern Med. 2004;164(20):2283.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Early Life Stress Enhances the Vulnerability to Chronic Psychosocial Stress and Experimental Colitis in Adult Mice
Veenema et al.
Endocrinology 2008;149:2727-2736.
ABSTRACT | FULL TEXT  

Experimental Endometriosis in the Rat Is Correlated With Colonic Motor Function Alterations but Not With Bacterial Load
Appleyard et al.
Reproductive Sciences 2007;14:815-824.
ABSTRACT  

Vanin-1 licenses inflammatory mediator production by gut epithelial cells and controls colitis by antagonizing peroxisome proliferator-activated receptor {gamma} activity
Berruyer et al.
JEM 2006;203:2817-2827.
ABSTRACT | FULL TEXT  

Chronic Intermittent Psychosocial Stress (Social Defeat/Overcrowding) in Mice Increases the Severity of an Acute DSS-Induced Colitis and Impairs Regeneration
Reber et al.
Endocrinology 2006;147:4968-4976.
ABSTRACT | FULL TEXT  

Progressive Proliferative and Dysplastic Typhlocolitis in Aging Syrian Hamsters Naturally Infected with Helicobacter spp.: A Spontaneous Model of Inflammatory Bowel Disease
Nambiar et al.
Vet Pathol 2006;43:2-14.
ABSTRACT | FULL TEXT  

Resolvin E1, an endogenous lipid mediator derived from omega-3 eicosapentaenoic acid, protects against 2,4,6-trinitrobenzene sulfonic acid-induced colitis
Arita et al.
Proc. Natl. Acad. Sci. USA 2005;102:7671-7676.
ABSTRACT | FULL TEXT  

Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells
Baumgart et al.
Gut 2005;54:228-236.
ABSTRACT | FULL TEXT  

Antisperm Antibodies in Inflammatory Bowel Disease
Rossato and Foresta
Arch Intern Med 2004;164:2283-2283.
FULL TEXT  

The Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado et al.
Pharmacol. Rev. 2004;56:249-290.
ABSTRACT | FULL TEXT  

Intestinal Nematode Infection Ameliorates Experimental Colitis in Mice
Khan et al.
Infect. Immun. 2002;70:5931-5937.
ABSTRACT | FULL TEXT